Design, synthesis, docking study and urease inhibitory activity evaluation of novel 2-((5-amino-1,3,4-thiadiazol-2-yl)thio)-N-arylacetamide derivatives
- 12 January 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Medicinal Chemistry Research
- Vol. 30 (3), 729-742
- https://doi.org/10.1007/s00044-020-02683-5
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Large-scale virtual screening for the identification of new Helicobacter pylori urease inhibitor scaffoldsJournal of Molecular Modeling, 2011
- Urease inhibitors as potential drugs for gastric and urinary tract infections: a patent reviewExpert Opinion on Therapeutic Patents, 2011
- Synthesis, antioxidant activities and urease inhibition of some new 1,2,4-triazole and 1,3,4-thiadiazole derivativesEuropean Journal of Medicinal Chemistry, 2010
- Synthesis and anticancer activity of 5-(3-indolyl)-1,3,4-thiadiazolesEuropean Journal of Medicinal Chemistry, 2010
- New potent inhibitors of tyrosinase: Novel clues to binding of 1,3,4-thiadiazole-2(3H)-thiones, 1,3,4-oxadiazole-2(3H)-thiones, 4-amino-1,2,4-triazole-5(4H)-thiones, and substituted hydrazides to the dicopper active siteBioorganic & Medicinal Chemistry, 2010
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityJournal of Computational Chemistry, 2009
- Kinetics of novel competitive inhibitors of urease enzymes by a focused library of oxadiazoles/thiadiazoles and triazolesBiochemical and Biophysical Research Communications, 2004
- ESOL: Estimating Aqueous Solubility Directly from Molecular StructureJournal of Chemical Information and Computer Sciences, 2004
- Motility of Urease-Deficient Derivatives of Helicobacter pyloriJournal of Bacteriology, 2004
- Simple Method of Calculating Octanol/Water Partition Coefficient.CHEMICAL & PHARMACEUTICAL BULLETIN, 1992